Literature DB >> 2380404

Plasma fibronectin concentrations in patients with human immunodeficiency virus infection.

D Torre1, M Issi, C Sampietro, G P Fiori, G Chelazzi, G Ferraro.   

Abstract

Plasma fibronectin (PFN) concentrations were assessed in 21 patients with AIDS, in seven with AIDS-related complex (ARC), in 17 asymptomatic seropositive patients, and in 36 age and sex matched healthy control subjects. A single radial immunodiffusion technique was used to determine PFN concentration. A significant decrease in PFN concentrations was observed in patients with ARC and AIDS (especially in those patients with Pneumocystis carinii pneumonitis). On the other hand, normal PFN concentrations were observed in asymptomatic seropositive patients. The determination of PFN concentration in patients with AIDS and ARC may contribute to the diagnosis of such patients.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2380404      PMCID： PMC502580          DOI： 10.1136/jcp.43.7.560

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


  18 in total

1.  Interaction of viral envelope glycoproteins with fibronectin.

Authors:  I Julkunen; A Hautanen; J Keski-Oja
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

Review 2.  Fibronectin: current concepts of its structure and functions.

Authors:  E Ruoslahti; E Engvall; E G Hayman
Journal:  Coll Relat Res       Date:  1981

3.  Fibronectin binds to Staphylococcus aureus.

Authors:  P Kuusela
Journal:  Nature       Date:  1978-12-14       Impact factor: 49.962

4.  In vitro binding of Candida albicans yeast cells to human fibronectin.

Authors:  K G Skerl; R A Calderone; E Segal; T Sreevalsan; W M Scheld
Journal:  Can J Microbiol       Date:  1984-02       Impact factor: 2.419

Review 5.  Physiology of fibronectin.

Authors:  D F Mosher
Journal:  Annu Rev Med       Date:  1984       Impact factor: 13.739

6.  Binding of human fibronectin to group A, C, and G streptococci.

Authors:  E B Myhre; P Kuusela
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

7.  Fibronectin increases the motility, phagocytosis and NBT (nitroblue tetrazolium)-reduction of granulocytes.

Authors:  C Jarstrand; T Ahlgren; L Berghem
Journal:  J Clin Lab Immunol       Date:  1982-05

8.  Plasma fibronectin values in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex.

Authors:  D M Ogden; H E Fischer; F J Liu; A Rios; B Lichtiger
Journal:  Am J Clin Pathol       Date:  1988-09       Impact factor: 2.493

9.  Factors influencing the incorporation of fibronectin into synovial fluid cryoprotein.

Authors:  S Carsons; B B Lavietes; H S Diamond
Journal:  J Lab Clin Med       Date:  1983-11

10.  Monocyte function in the acquired immune deficiency syndrome. Defective chemotaxis.

Authors:  P D Smith; K Ohura; H Masur; H C Lane; A S Fauci; S M Wahl
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808
View more
  9 in total

1.  Expression of the alpha 5 beta 1 fibronectin receptor on T lymphocytes of patients with HIV-1 infection.

Authors:  D Torre; G Ferrario; M Issi; A Pugliese; F Speranza
Journal:  J Clin Pathol       Date:  1996-09       Impact factor: 3.411

2.  Plasma fibronectin levels in patients with HIV-1 infection (Infection 22 [1994] 116)

Authors:  A Rodriguez-Cuartero; J Núñez-Carril
Journal:  Infection       Date:  1994 May-Jun       Impact factor: 3.553

3.  Re: Rodriguez-Cuartero et al: plasma fibronectin levels in patients with HIV-1 infection (Infection 21 [1993] 303-305).

Authors:  D Torre; C Zeroli; M Giola; M Issi; R Martegani
Journal:  Infection       Date:  1994 Mar-Apr       Impact factor: 3.553

4.  Plasma fibronectin concentrations in patients with HIV infection and visceral leishmaniasis.

Authors:  A Rodríguez-Cuartero; J Nuñez-Carrill; A Salas-Galán; M A Rodríguez-Rodríguez
Journal:  Infection       Date:  1993 Sep-Oct       Impact factor: 3.553

5.  Monocyte CD49e and 110-120 kDa fibronectin fragments: HIV prognostic indicators independent of viral load and CD4 T-cell counts.

Authors:  Roger D Rossen; Jose A Rubio; Wendy J Porter; JoAnn Trial; Frank M Orson; Maria C Rodriguez-Barradas; Holly H Birdsall
Journal:  AIDS       Date:  2009-11-13       Impact factor: 4.177

6.  Cerebrospinal fluid concentration of fibronectin in patients with HIV-1 infection and central nervous system disorders.

Authors:  D Torre; C Zeroli; G Ferrario; G Bonetta; G P Fiori; R Martegani
Journal:  J Clin Pathol       Date:  1993-11       Impact factor: 3.411

7.  Levels of circulating fibronectin receptor in adult and pediatric patients with human immunodeficiency virus type 1 infection.

Authors:  D Torre; C Zeroli; A Pugliese; M Giola; G Ferrario; G Bonetta; M Issi; R Martegani; F Speranza; G P Fiori
Journal:  Clin Diagn Lab Immunol       Date:  1994-05

8.  Slit2/Robo4 signaling modulates HIV-1 gp120-induced lymphatic hyperpermeability.

Authors:  Xuefeng Zhang; Jinlong Yu; Paula M Kuzontkoski; Weiquan Zhu; Dean Y Li; Jerome E Groopman
Journal:  PLoS Pathog       Date:  2012-01-05       Impact factor: 6.823

9.  Identification of a CD36-related thrombospondin 1-binding domain in HIV-1 envelope glycoprotein gp120: relationship to HIV-1-specific inhibitory factors in human saliva.

Authors:  R Crombie; R L Silverstein; C MacLow; S F Pearce; R L Nachman; J Laurence
Journal:  J Exp Med       Date:  1998-01-05       Impact factor: 14.307
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.